Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 Vectors

被引:1
|
作者
Richter, Maximilian [1 ]
Wang, Hongjie [1 ]
Lieber, Andre [1 ]
机构
[1] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
关键词
oncolytic virus; serotype; 3; desmoglein; 2; coagulation factor X; ONCOLYTIC ADENOVIRUS; INTRAVENOUS-INJECTION; GENE-TRANSFER; DESMOGLEIN; IN-VITRO; EXPRESSION; THERAPY; CELLS; TRANSDUCTION; FLEXIBILITY;
D O I
10.3390/genes13112056
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Desmoglein 2 (DSG2) is overexpressed in many epithelial cancers and therefore represents a target receptor for oncolytic viruses, including Ad5/3-based viruses. For most Ad serotypes, the receptor-binding fiber is composed of tail, shaft, and knob domains. Here, we investigated the role of the fiber shaft in Ad5/3 tumor transduction in vitro and in human DSG2-transgenic mice carrying human DSG2(high) tumors. DSG2tg mice express DSG2 in a pattern similar to humans. We constructed Ad5/3L (with the "long" Ad5 shaft) and Ad5/3S (with the "short" Ad3 shaft) expressing GFP or luciferase. In in vitro studies we found that coagulation factor X, which is known to mediate undesired hepatocyte transduction of Ad5, enhances the transduction of Ad5/3(L), but not the transduction of Ad5/3(S). We therefore hypothesized that Ad5/3(S) would target DSG2(high) tumors while sparing the liver after intravenous injection. In vivo imaging studies for luciferase and analysis of luciferase activity in isolated organs, showed that Ad5/3(L) vectors efficiently transduced DSG2(high) tumors and liver but not normal epithelial tissues after intravenous injection. Ad5/3(S) showed minimal liver transduction, however it failed to transduce DSG2(high) tumors. Further modifications of the Ad5/3(S) capsid are required to compensate for the lower infectivity of Ad5/3(S) vectors.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy
    Han, Tie
    Tang, Yizhe
    Ugai, Hideyo
    Perry, Leslie E.
    Siegal, Gene P.
    Contreras, Juan L.
    Wu, Hongju
    VIROLOGY JOURNAL, 2007, 4 (1)
  • [42] Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells
    Gao, Jian
    Zhang, Wenli
    Mese, Kemal
    Bunz, Oskar
    Lu, Fengmin
    Ehrhardt, Anja
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 18 : 376 - 389
  • [43] A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism
    Takayama, K
    Reynolds, PN
    Short, JS
    Kawakami, Y
    Adachi, Y
    Glasgow, JN
    Rots, MG
    Krasnykh, VN
    Douglas, JT
    Curiel, DT
    MOLECULAR THERAPY, 2003, 7 (05) : S51 - S51
  • [44] Transduction profiles of FX-binding ablated Ad5 vectors in non-human primates (Microcebus murinus)
    Alba, R.
    Bradshaw, A. C.
    Mestre-Frances, N.
    Verdier, J. M.
    Henaff, D.
    Baker, A. H.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1397 - 1398
  • [45] FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment
    Hartmann, K. Patricia
    van Gogh, Merel
    Freitag, Patrick C.
    Kast, Florian
    Nagy-Davidescu, Gabriela
    Borsig, Lubor
    Pluckthun, Andreas
    MOLECULAR THERAPY, 2023, 31 (10) : 2914 - 2928
  • [46] Evaluation of Dose, Scheduling, Combination with Chemotherapy and Specificity of Ad5/3 Fiber-Chimeric Oncolytic Adenoviruses for Treatment of Ovarian Cancer
    Raki, Mari
    Kangasniemi, Lotta
    Kanerva, Anna
    Bauerschmitz, Gerd
    Isoniemi, Helena
    Hockerstedt, Krister
    Hemminki, Akseli
    MOLECULAR THERAPY, 2006, 13 : S249 - S249
  • [47] Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers
    Cho, Young-Suk
    Do, Manh-Hung
    Kwon, Se-Young
    Moon, Changjong
    Kim, Kwonseop
    Lee, Keesook
    Lee, Sang-Jin
    Hemmi, Silvio
    Joo, Young-Eun
    Kim, Min Soo
    Jung, Chaeyong
    ONCOTARGET, 2016, 7 (25) : 38210 - 38223
  • [48] Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
    Geisbert, Thomas W.
    Bailey, Michael
    Hensley, Lisa
    Asiedu, Clement
    Geisbert, Joan
    Stanley, Daphne
    Honko, Anna
    Johnson, Joshua
    Mulangu, Sabue
    Pau, Maria Grazia
    Custers, Jerome
    Vellinga, Jort
    Hendriks, Jenny
    Jahrling, Peter
    Roederer, Mario
    Goudsmit, Jaap
    Koup, Richard
    Sullivan, Nancy J.
    JOURNAL OF VIROLOGY, 2011, 85 (09) : 4222 - 4233
  • [49] Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors
    Schroers, R
    Hildebrandt, Y
    Hasenkamp, J
    Glass, B
    Lieber, A
    Wulf, G
    Piesche, M
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (06) : 536 - 546
  • [50] Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy
    Shimada, M.
    Wang, H. -B
    Kondo, A.
    Xu, X. -P
    Yoshida, A.
    Shinoda, K.
    Ura, T.
    Mizuguchi, H.
    Klinman, D.
    Luo, J. -L
    Bai, H.
    Okuda, K.
    GENE THERAPY, 2009, 16 (02) : 218 - 228